Identifyingspecific downstream targets regulated by PPARs in the pulmonary vasculaturewill facilitate the development of potential PPAR-related therapeuticstrategies for the prevention or treatment of pulmonary hypertension. This evidence concerns the gene PPARA and pulmonary arterial hypertension.